Can Cenforce Fm 100 Mg use reduce the risk of prostate cancer? | Forum

Cenforce FM 100 mg contains sildenafil citrate, which is primarily used to treat erectile dysfunction (ED) in men and improve blood flow by relaxing blood vessels. However, it is not clinically proven to reduce the risk of prostate cancer. Some studies have examined phosphodiesterase type 5 (PDE5) inhibitors like sildenafil to see if they have any role in improving prostate-related conditions, such as benign prostatic hyperplasia (BPH). While these drugs can relieve urinary symptoms due to improved blood flow and smooth muscle relaxation, they do not prevent or reduce prostate cancer risk. The risk of prostate cancer is primarily influenced by factors like age, genetics, lifestyle, diet, and family history. Reducing this risk usually involves lifestyle changes, regular screenings, and discussions with a healthcare provider.